We collaborate with academic, patient and industry groups to quickly progress new rare disease treatments through the clinic and towards patients
Ways of working together
True medical breakthroughs happen when industry, patient groups and academic institutions work together. And whilst cutting-edge AI technology is integral to our work, we recognise that without the involvement of our partners we couldn’t have achieved as much as we have done to date.
We welcome enquiries from groups working on rare conditions where relevant assets, resources and data are available. If you are interested in partnering with us to progress treatments for your disease of interest please get in touch.
Rare Treatment Accelerator
Our Rare Treatment Accelerator (RTA) helps academic, patient, and industry groups advance their rare disease drug redevelopment projects. By combining our team, expertise and financial resources with your research and insights, we can get treatments to patients faster.
For all other questions, please email our team at email@example.com